| HOME >> BIOLOGY >> TECHNOLOGY |
flovagatran 68
Biological E Collaborates with Choncept and Heparinex 68
Bayer's Market Expansion 68
B. Braun Recalls Heparin Sodium Based Injection Solutions 68
Baxter Recalls Heparin Sodium Vials 69
Celgene Acquires Pharmion 69
BMS Collaborates with Pfizer 69
Medicines Company Reacquires European Rights for Angiox 70
HemoSense and LabCorp Sign Agreement for Supply of INRatio System 70
Sanofi-Aventis Acquires Rights for Panaldine from Daiichi 70
Alchemia Inks Marketing Alliance with Dr Reddy's for Heparin 71
Inverness Announces Acquisition of HemoSense 71
ev3, FoxHollow Complete Merger 71
Osmetech Signs Licensing Agreement with Marshfield Clinic 72
Mitsubishi and Tanabe Agree to Merge 72
Artisan and A-Bio Form Alliance 72
Archemix and Nuvelo Announces Expansion of Alliance 72
American Capital Acquires Scientific Protein Laboratories' One
Stop Buyout™ 72
Bristol-Myers to Start New Facility in Massachusetts 73
AstraZeneca Stops Development of Exanta 73
Pfizer Enters into Agreement with BPC 73
12. FOCUS ON SELECT GLOBAL PLAYERS 74
AstraZeneca PLC (UK) 74
Bristol-Myers Squibb Company (USA) 74
GlaxoSmithKline plc (UK) 74
LEO Pharmaceutical Products (Denmark) 75
Mitsubishi Tanabe Pharma Corporation (Japan) 75
Pfizer Inc. (USA) 76
Sanofi-Aventis (France) 76
Teva Pharmaceutical Industries Ltd (Israel) 76
Teva Pharmaceuticals USA (US) 77
13. GLOBAL MARKET PERSPECTIVE 78
Table 3: World Recent Past, Current & Future Analysis for
Anticoagulants by Geographic Region/Country - US, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 includes corresponding Graph/Chart) 78
Table 4: World Historic Review for An
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |